Circulating oxidized low density lipoprotein levels - A biochemical risk marker for coronary heart disease

被引：315
|
作者：
Toshima, S
Hasegawa, A
Kurabayashi, M
Itabe, H
Takano, T
Sugano, J
Shimamura, K
Kimura, J
Michishita, I
Suzuki, T
Nagai, R
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan
[2] Gunma Univ, Sch Med, Dept Internal Med 2, Gunma, Japan
[3] Saiseikai Maebashi Hosp, Dept Internal Med, Gunma, Japan
[4] Gunma Chuoh Gen Hosp, Dept Internal Med, Gunma, Japan
[5] Teikyo Univ, Fac Pharmaceut Sci, Dept Microbiol & Mol Pathol, Sagamiko, Kanagawa 19901, Japan
[6] Vessel Res Lab Co Ltd, Kanagawa, Japan
[7] Yokohama Sakae Kyosai Hosp, Dept Internal Med, Kanagawa, Japan
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2000年 / 20卷 / 10期
关键词：
oxidized low density lipoprotein; coronary heart disease; risk factors;
D O I：
10.1161/01.ATV.20.10.2243
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Recent studies have established oxidative modification of low density lipoprotein (LDL) as an important atherogenic factor. We examined the clinical relevance of circulating oxidized LDL (OxLDL) levels in atherosclerotic disease by an enzyme immunoassay with use of specific antibodies against OxLDL (FOH1a/DLH3) and apolipoprotein B, Plasma OxLDL levels were significantly higher in patients with coronary heart disease (n=65) than in control subjects (n=181; 201.3+/-11.2 versus 112.4+/-3.3 U/dL, respectively; P<0.01). OxLDL levels were not associated with age, sex, total cholesterol, or apolipoprotein B levels in normal control subjects. Our results suggest that circulating OxLDL may be a possible biochemical risk marker for coronary heart disease.
引用
收藏
页码：2243 / 2247
页数：5
相关论文
共 50 条
  • [1] Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease
    Suzuki, T
    Kohno, H
    Hasegawa, A
    Toshima, S
    Amaki, T
    Kurabayashi, M
    Nagai, R
    CLINICAL BIOCHEMISTRY, 2002, 35 (05) : 347 - 353
  • [2] Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of atherosclerotic disease
    Suzuki, T
    Kohno, H
    Toshima, S
    Hasegawa, A
    Kurabayashi, M
    Nagai, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 248A - 248A
  • [3] Circulating Oxidized Low-Density Lipoprotein is a Strong Risk Factor for the Early Stage of Coronary Heart Disease
    Zhang, Qiang
    Ai, Yongshun
    Dong, Huiqiu
    Wang, Junsong
    Xu, Li
    IUBMB LIFE, 2019, 71 (02) : 277 - 282
  • [4] Elevated oxidized low-density lipoprotein levels in patients with coronary heart disease
    Toshima, S
    Fukuda, T
    Amano, M
    Hasegawa, A
    Sugano, J
    Uchiyama, H
    Shimamura, K
    Kimura, J
    Nagai, R
    CIRCULATION, 1996, 94 (08) : 1288 - 1288
  • [5] Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine in coronary heart disease
    Faviou, E
    Vourli, G
    Nounopoulos, CH
    Zachari, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 64 - 64
  • [6] Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk
    Tsimikas, S
    Witztum, JL
    CIRCULATION, 2001, 103 (15) : 1930 - 1932
  • [7] Circulating malondialdehyde-modified LDL levels in patients with coronary heart disease; A biochemical risk marker for coronary heart disease
    Amaki, T
    Suzuki, T
    Nakamura, F
    Hayashi, D
    Imai, Y
    Morita, H
    Nojiri, T
    Yamazaki, T
    CIRCULATION, 2002, 106 (19) : 188 - 189
  • [8] Comparison between high density lipoprotein, lipoprotein (a) and small dense low density lipoprotein as a risk marker of coronary heart disease
    Priyana, Adi
    UNIVERSA MEDICINA, 2007, 26 (01) : 11 - 17
  • [9] Association between Serum Ferritin and Circulating Oxidized Low-density Lipoprotein Levels in Patients with Coronary Artery Disease
    Khalili, Ahmadali
    Ghorbanihaghjo, Amir
    Rashtchizadeh, Nadereh
    Gaffari, Samad
    JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 2012, 4 (01) : 1 - 4
  • [10] CIRCULATING OXIDIZED LOW-DENSITY LIPOPROTEIN LEVELS MAY SERVE AS A RISK MARKER FOR CAROTID STENOSIS DURING STATIN THERAPY
    Kougialis, S.
    Levisianou, D.
    Skopelitis, E.
    Nikolaou, S.
    Kroustalis, A.
    Gogalis, T.
    Groumas, G.
    Zervou, A.
    Kosmas, N.
    Iliopoulos, N.
    Mpilinis, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 115 - 116
12345